Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $886.54 million. The enterprise value is $638.53 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IOVA has 361.85 million shares outstanding. The number of shares has increased by 20.18% in one year.
Current Share Class | 361.85M |
Shares Outstanding | 361.85M |
Shares Change (YoY) | +20.18% |
Shares Change (QoQ) | +3.61% |
Owned by Insiders (%) | 8.09% |
Owned by Institutions (%) | 58.26% |
Float | 308.18M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.21 |
Forward PS | 3.29 |
PB Ratio | 1.20 |
P/TBV Ratio | 2.20 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.64 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.08.
Current Ratio | 3.27 |
Quick Ratio | 2.80 |
Debt / Equity | 0.08 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.16% and return on invested capital (ROIC) is -32.04%.
Return on Equity (ROE) | -53.16% |
Return on Assets (ROA) | -27.42% |
Return on Invested Capital (ROIC) | -32.04% |
Return on Capital Employed (ROCE) | -52.76% |
Revenue Per Employee | $288,216 |
Profits Per Employee | -$465,300 |
Employee Count | 838 |
Asset Turnover | 0.26 |
Inventory Turnover | 4.94 |
Taxes
In the past 12 months, IOVA has paid $188,000 in taxes.
Income Tax | 188,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.71% in the last 52 weeks. The beta is 0.88, so IOVA's price volatility has been lower than the market average.
Beta (5Y) | 0.88 |
52-Week Price Change | -75.71% |
50-Day Moving Average | 2.25 |
200-Day Moving Average | 4.82 |
Relative Strength Index (RSI) | 49.87 |
Average Volume (20 Days) | 26,427,678 |
Short Selling Information
The latest short interest is 67.71 million, so 18.71% of the outstanding shares have been sold short.
Short Interest | 67.71M |
Short Previous Month | 98.63M |
Short % of Shares Out | 18.71% |
Short % of Float | 21.97% |
Short Ratio (days to cover) | 2.93 |
Income Statement
In the last 12 months, IOVA had revenue of $241.53 million and -$389.92 million in losses. Loss per share was -$1.23.
Revenue | 241.53M |
Gross Profit | 49.75M |
Operating Income | -410.64M |
Pretax Income | n/a |
Net Income | -389.92M |
EBITDA | -376.29M |
EBIT | -410.64M |
Loss Per Share | -$1.23 |
Full Income Statement Balance Sheet
The company has $301.18 million in cash and $53.17 million in debt, giving a net cash position of $248.02 million or $0.69 per share.
Cash & Cash Equivalents | 301.18M |
Total Debt | 53.17M |
Net Cash | 248.02M |
Net Cash Per Share | $0.69 |
Equity (Book Value) | 698.49M |
Book Value Per Share | 2.04 |
Working Capital | 293.35M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$303.41 million and capital expenditures -$20.13 million, giving a free cash flow of -$323.54 million.
Operating Cash Flow | -303.41M |
Capital Expenditures | -20.13M |
Free Cash Flow | -323.54M |
FCF Per Share | -$0.89 |
Full Cash Flow Statement Margins
Gross margin is 20.60%, with operating and profit margins of -170.02% and -161.44%.
Gross Margin | 20.60% |
Operating Margin | -170.02% |
Pretax Margin | -161.36% |
Profit Margin | -161.44% |
EBITDA Margin | -155.80% |
EBIT Margin | -170.02% |
FCF Margin | n/a |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -20.18% |
Shareholder Yield | -20.18% |
Earnings Yield | -43.98% |
FCF Yield | -36.49% |
Dividend Details Analyst Forecast
The average price target for IOVA is $11.90, which is 385.71% higher than the current price. The consensus rating is "Buy".
Price Target | $11.90 |
Price Target Difference | 385.71% |
Analyst Consensus | Buy |
Analyst Count | 11 |
Revenue Growth Forecast (5Y) | 46.42% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 1:100.
Last Split Date | Sep 26, 2013 |
Split Type | Reverse |
Split Ratio | 1:100 |
Scores
IOVA has an Altman Z-Score of 0.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.95 |
Piotroski F-Score | 3 |